Link to this page
Biological and Environmental Research Ontology
Last uploaded:
December 23, 2022
| Id | http://purl.obolibrary.org/obo/NCIT_C90579
http://purl.obolibrary.org/obo/NCIT_C90579
|
|---|---|
| Preferred Name | Anti-HER2 Monoclonal Antibody CT-P6 |
| Definitions |
A monoclonal antibody directed against the human epidermal growth factor receptor 2 (HER2) with potential immunomodulating and antineoplastic activity. After binding to HER2 on the tumor cell surface, anti-HER2 monoclonal antibody CT-P6 may induce a cytotoxic T-lymphocyte (CTL) as well as an antibody-dependent cell-mediated cytotoxicity (ADCC) against tumor cells that overexpress HER2. HER2, a tyrosine kinase receptor, is overexpressed by many cancer cell types.
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| definition | A monoclonal antibody directed against the human epidermal growth factor receptor 2 (HER2) with potential immunomodulating and antineoplastic activity. After binding to HER2 on the tumor cell surface, anti-HER2 monoclonal antibody CT-P6 may induce a cytotoxic T-lymphocyte (CTL) as well as an antibody-dependent cell-mediated cytotoxicity (ADCC) against tumor cells that overexpress HER2. HER2, a tyrosine kinase receptor, is overexpressed by many cancer cell types. |
|---|---|
| prefLabel | Anti-HER2 Monoclonal Antibody CT-P6
|
| label | Anti-HER2 Monoclonal Antibody CT-P6
|
| NCI_META_CUI | CL416272
|
| PDQ_Closed_Trial_Search_ID | 668193
|
| code | C90579
|
| Has_Target | |
| prefixIRI | NCIT:C90579
|
| in_subset | |
| Preferred_Name | Anti-HER2 Monoclonal Antibody CT-P6
|
| Maps_To | Anti-HER2 Monoclonal Antibody CT-P6
|
| NCI_Drug_Dictionary_ID | 668193
|
| type | |
| Is_Value_For_GDC_Property | |
| subClassOf | |
| PDQ_Open_Trial_Search_ID | 668193
|
| Semantic_Type |
Amino Acid, Peptide, or Protein
Pharmacologic Substance
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |